FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rudolf Berger

Research Profile

Disorders

Heart Failure

Chemicals & Drugs

Concepts & Ideas

Physiology

Geographic Areas

Austria

Co-author Network

Publications

TOP 3
Deddo Moertl; Sabine Steiner; Doug Coyle; Rudolf Berger
Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.
Vanessa Berger-Kulemann; Michael Gruber; Sarah Pötter-Lang; Werner Rabitsch; Karin Vonbank; Michael Weber; Rudolf Berger; Martin Uffmann
Needle image plates compared to conventional CR in chest radiography: is dose reduction possible?
Deddo Moertl; Rudolf Berger; Alexandra Hammer; Raisa Hutuleac; Christoph W Kopp; Renate Koppensteiner; Sabine Steiner
Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rudolf Berger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Deddo Moertl; Sabine Steiner; Doug Coyle; Rudolf Berger
Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.
International journal of technology assessment in health care 2013;29(1):3-11.
2012: Vanessa Berger-Kulemann; Michael Gruber; Sarah Pötter-Lang; Werner Rabitsch; Karin Vonbank; Michael Weber; Rudolf Berger; Martin Uffmann
Needle image plates compared to conventional CR in chest radiography: is dose reduction possible?
European journal of radiology 2012;81(12):4156-60.
2011: Deddo Moertl; Rudolf Berger; Alexandra Hammer; Raisa Hutuleac; Christoph W Kopp; Renate Koppensteiner; Sabine Steiner
Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure.
Thrombosis and haemostasis 2011;106(3):457-65.
2011: Kathrin Rychli; Johann Wojta; Gerlinde Zorn; Rudolf Berger; Philipp J Hohensinner; Kurt Huber; Ali Kariem Mahdy; Deddo Mörtl; Stephanie Neuhold; Alexander Niessner; Richard Pacher; Bernhard Richter; Martin Hülsmann
Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Heart (British Cardiac Society) 2011;97(14):1158-63.
2011: Deddo Moertl; Alexandra Hammer; Sabine Steiner; Raisa Hutuleac; Karin Vonbank; Rudolf Berger
Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.
American heart journal 2011;161(5):915.e1-9.
2011: Christopher Adlbrecht; Martin Huelsmann; Rudolf Berger; Deddo Moertl; Guido Strunk; August Oesterle; Roozbeh Ahmadi; Thomas Szucs; Richard Pacher
Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care.
European journal of clinical investigation 2011;41(3):315-22.
2010: Bernhard Richter; Kathrin Rychli; Philipp J Hohensinner; Rudolf Berger; Deddo Mörtl; Stephanie Neuhold; Gerlinde Zorn; Kurt Huber; Gerald Maurer; Johann Wojta; Richard Pacher; Martin Hülsmann; Alexander Niessner
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.
Atherosclerosis 2010;213(2):545-8.
2010: Kathrin Rychli; Alexander Niessner; Philipp J Hohensinner; Kariem Mahdy Ali; Christoph Kaun; Stephanie Neuhold; Gerlinde Zorn; Bernhard Richter; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Kurt Huber; Gerald Maurer; Richard Pacher; Johann Wojta
Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.
Chest 2010;138(3):656-64.
2010: Rudolf Berger; Deddo Moertl; Sieglinde Peter; Roozbeh Ahmadi; Martin Huelsmann; Susan Yamuti; Brunhilde Wagner; Richard Pacher
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Journal of the American College of Cardiology 2010;55(7):645-53.
2010: Philipp J Hohensinner; Kathrin Rychli; Gerlinde Zorn; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Bernhard Richter; Kurt Huber; Johann Wojta; Richard Pacher; Alexander Niessner
Macrophage-modulating cytokines predict adverse outcome in heart failure.
Thrombosis and haemostasis 2010;103(2):435-41.
2009: Deddo Moertl; Rudolf Berger; Joachim Struck; Andreas Gleiss; Alexandra Hammer; Nils G. Morgenthaler; Andreas Bergmann; Martin Huelsmann; Richard Pacher
Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Journal of the American College of Cardiology 2009;53(19):1783-90.
2009: Deddo Moertl; Rudolf Berger; Alexandra Hammer; Martin Huelsmann; Raisa Hutuleac; Richard Pacher
B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.
Journal of cardiac failure 2009;15(3):233-40.
2009: Alexander Niessner; Philipp J Hohensinner; Kathrin Rychli; Stephanie Neuhold; Gerlinde Zorn; Bernhard Richter; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Kurt Huber; Johann Wojta; Richard Pacher
Prognostic value of apoptosis markers in advanced heart failure patients.
European heart journal 2009;30(7):789-96.
2009: Christopher Adlbrecht; Martin Hülsmann; Guido Strunk; Rudolf Berger; Deddo Mörtl; Joachim Struck; Nils G. Morgenthaler; Andreas Bergmann; Johannes Jakowitsch; Gerald Maurer; Irene M Lang; Richard Pacher
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
European journal of heart failure 2009;11(4):361-6.
2008: Christopher Adlbrecht; Spyridoula Kommata; Martin Hülsmann; Thomas Szekeres; Christian Bieglmayer; Guido Strunk; Georgios Karanikas; Rudolf Berger; Deddo Mörtl; Kurt Kletter; Gerald Maurer; Irene M Lang; Richard Pacher
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.
European heart journal 2008;29(19):2343-50.
2008: Martin Huelsmann; Stephanie Neuhold; Guido Strunk; Deddo Moertl; Rudolf Berger; Rudolf Prager; Heidemarie Abrahamian; Michaela Riedl; Richard Pacher; Anton Luger; Martin Clodi
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.
European heart journal 2008;29(18):2259-64.
2008: Stephanie Neuhold; Martin Huelsmann; Guido Strunk; Brigitte Stoiser; Joachim Struck; Nils G. Morgenthaler; Andreas Bergmann; Deddo Moertl; Rudolf Berger; Richard Pacher
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Journal of the American College of Cardiology 2008;52(4):266-72.
2008: Deddo Moertl; Alexandra Hammer; Martin Huelsmann; Richard Pacher; Rudolf Berger
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients.
European journal of heart failure 2008;10(4):404-11.
2007: Brigitte Meyer; Martin Huelsmann; Paul Wexberg; Georg Delle-Karth; Rudolf Berger; Deddo Moertl; Thomas Szekeres; Richard Pacher; Gottfried Heinz
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
Critical care medicine 2007;35(10):2268-73.
2007: Rudolf Berger; Deddo Moertl; Martin Huelsmann; Anja Bojic; Roozbeh Ahmadi; Isabella Heissenberger; Richard Pacher
Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
European journal of heart failure 2007;9(2):202-8.
2006: Brigitte Meyer; Deddo Moertl; Martin Huelsmann; Vanessa Kulemann; Andreas Zuckermann; Michael Grimm; Richard Pacher; Rudolf Berger
Heart transplantation provides long-term survival benefit in stable patients experiencing heart failure without reverse left ventricular remodeling.
Transplantation 2006;82(11):1463-71.
2006: Brigitte Stoiser; Deddo Mörtl; Martin Hülsmann; Rudolf Berger; Joachim Struck; Nils G. Morgenthaler; A Bergmann; Richard Pacher
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
European journal of clinical investigation 2006;36(11):771-8.
2005: Marianne Gwechenberger; Richard Pacher; Rudolf Berger; Gerlinde Zorn; Petra Moser; Brigitte Stanek; Martin Huelsmann
Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(12):2190-5.
2005: Deddo Moertl; Rudolf Berger; Martin Huelsmann; Anja Bojic; Richard Pacher
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure.
European journal of heart failure 2005;7(7):1156-63.
2005: Brigitte Meyer; Deddo Mörtl; Karin Strecker; Martin Hülsmann; Vanessa Kulemann; Thomas Neunteufl; Richard Pacher; Rudolf Berger
Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide.
Journal of the American College of Cardiology 2005;46(6):1011-8.
2005: Rudolf Berger
B-type natriuretic peptide is a strong prognostic indicator for people with heart failure. Commentary.
Evidence-based cardiovascular medicine 2005;9(3):194-6.
2005: Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Richard Pacher
Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure Survey.
European journal of heart failure 2005;7(4):657-61.
2005: Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Odette Gore; Brigitte Meyer; Richard Pacher
Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
European journal of heart failure 2005;7(4):552-6.
2005: Maria Koreny; Peter Reinelt; Brigitte Meyer; Georg Delle-Karth; Alexander Geppert; Martin Hülsmann; Ute Priglinger; Rudolf Berger; Gottfried Heinz
Dynamics of inflammation parameters prior to tachyarrhythmias in critically ill patients.
Wiener klinische Wochenschrift 2005;117(9-10):342-7.
2005: Rudolf Berger; Martin Huelsmann; Karin Strecker; Deddo Moertl; Petra Moser; Anja Bojic; Richard Pacher
Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
European journal of clinical investigation 2005;35(1):24-31.
2004: Marianne Gwechenberger; Martin Huelsmann; Senta Graf; Rudolf Berger; Diana Bonderman; Brigitte Stanek; F Rauscha; Richard Pacher
Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
European journal of clinical investigation 2004;34(12):811-7.
2004: Marianne Gwechenberger; Martin Hülsmann; Rudolf Berger; Senta Graf; Christoph Springer; Brigitte Stanek; Richard Pacher
Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2004;23(7):839-44.
2004: Martin Hülsmann; Michael Quittan; Rudolf Berger; Richard Crevenna; Christoph Springer; Martin Nuhr; Deddo Mörtl; Petra Moser; Richard Pacher
Muscle strength as a predictor of long-term survival in severe congestive heart failure.
European journal of heart failure 2004;6(1):101-7.
2004: Jutta Bergler-Klein; Richard Pacher; Rudolf Berger; Anja Bojic; Brigitte Stanek
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2004;23(1):20-7.
2004: Martin Nuhr; Dirk Pette; Rudolf Berger; Michael Quittan; Richard Crevenna; Martin Huelsman; Günther F Wiesinger; Petra Moser; Veronika Fialka-Moser; Richard Pacher
Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure.
European heart journal 2004;25(2):136-43.
2003: Georg Delle-Karth; Anton Buberl; Alexander Geppert; Thomas Neunteufl; Martin Huelsmann; C Kopp; Mariam Nikfardjam; Rudolf Berger; Gottfried Heinz
Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
Acta anaesthesiologica Scandinavica 2003;47(10):1251-6.
2003: Rudolf Berger; Karin Strecker; Martin Huelsmann; Petra Moser; Bernhard Frey; Anja Bojic; Brigitte Stanek; Richard Pacher
Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2003;22(9):1037-45.
2003: Ursula Klaar; Rudolf Berger; Marianne Gwechenberger; Michael Wutte; Gerold Porenta; Heinz Sochor; Gerald Maurer; Helmut Baumgartner
Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2003;16(9):949-57.
2003: Georg Delle-Karth; Peter Reinelt; Anton Buberl; Alexander Geppert; Martin Huelsmann; Rudolf Berger; Gottfried Heinz
Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU.
Intensive care medicine 2003;29(6):963-8.
2003: Ute Priglinger; Georg Delle-Karth; Alexander Geppert; Christian Joukhadar; Senta Graf; Rudolf Berger; M Hülsmann; Susanne Spitzauer; Ingrid Pabinger; Gottfried Heinz
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
Critical care medicine 2003;31(5):1405-9.
2002: Martin Hülsmann; Rudolf Berger; Brigitte Sturm; Anja Bojic; Wolfgang Woloszczuk; Jutta Bergler-Klein; Richard Pacher
Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
European heart journal 2002;23(11):886-91.
2002: Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
Circulation 2002;105(20):2392-7.
2002: Rainer Hubmann; Josef D Schwarzmeier; Medhat Shehata; Martin Hilgarth; Markus Duechler; Markus Dettke; Rudolf Berger
Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Blood 2002;99(10):3742-7.
2002: Thomas Neunteufl; Rudolf Berger; Richard Pacher
Endothelin receptor antagonists in cardiology clinical trials.
Expert opinion on investigational drugs 2002;11(3):431-43.
2002: Martin Huelsmann; Thomas Stefenelli; Rudolf Berger; Bernhard Frey; Richard Pacher
Prognostic impact of workload in patients with congestive heart failure.
American heart journal 2002;143(2):308-12.
2002: Markus Dettke; Rudolf Berger; S Jurko; Gerlinde Mitterbauer; Josef D Schwarzmeier; Paul Höcker
Selection of autologous CD4+ T-cells for adoptive T-cell substitution in patients with CD23+ B-cell CLL.
Cytotherapy 2002;4(2):119-25.
2001: Martin Hülsmann; Brigitte Sturm; Richard Pacher; Rudolf Berger; Anja Bojic; Bernhard Frey; Brigitte Stanek
Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2001;20(11):1174-80.
2001: Brigitte Stanek; Bernhard Frey; Martin Hülsmann; Rudolf Berger; Brigitte Sturm; Jeanette Strametz-Juranek; Jutta Bergler-Klein; Petra Moser; Anja Bojic; E Hartter; Richard Pacher
Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
Journal of the American College of Cardiology 2001;38(2):436-42.
2001: Rudolf Berger; Brigitte Stanek; Martin Hülsmann; Bernhard Frey; Sandra Heher; Richard Pacher; Thomas Neunteufl
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
Circulation 2001;103(7):981-6.
2000: Brigitte Sturm; Richard Pacher; Jeanette Strametz-Juranek; Rudolf Berger; Bernhard Frey; Brigitte Stanek
Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril.
European journal of heart failure 2000;2(4):407-12.
2000: Rudolf Berger; Karin Strecker; Martin Hülsmann; Bernhard Frey; Richard Pacher; Brigitte Stanek
Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(11):1081-8.
2000: Martin Hülsmann; Thomas Stefenelli; Rudolf Berger; Brigitte Sturm; A Parkner; Andreas Zuckermann; Wolfgang Woloszczuk; Richard Pacher
Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(10):939-45.
2000: Medhat Shehata; Josef D Schwarzmeier; S T Nguyen; Martin Hilgarth; Rudolf Berger; Rainer Hubmann; S Kickmaier; T Decker
Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Cancer research 2000;60(19):5420-6.
2000: Rudolf Berger; Gerald Kuchling; Bernhard Frey; I Kozanly; Richard Pacher; Brigitte Stanek
ACE inhibitor dosage at the time of listing predicts survival.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(2):127-33.
2000: Jutta Bergler-Klein; Bernhard Schlechta; Brigitte Stanek; Martin Hülsmann; Rudolf Berger; Michael Grimm; Richard Pacher
[Heart transplantation: indications and guidelines].
Wiener klinische Wochenschrift 2000;112(23 Pt A):14-6, 18-20.
1999: G Gruber; Josef D Schwarzmeier; Medhat Shehata; Martin Hilgarth; Rudolf Berger
Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia.
Blood 1999;94(3):1077-85.
1999: Brigitte Stanek; Brigitte Sturm; Bernhard Frey; Martin Hülsmann; Anja Bojic; Rudolf Berger; Suzanne Rödler; Gottfried Locker; Michael Grimm; Günther Laufer; Richard Pacher
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1999;18(4):358-66.
1999: Brigitte Stanek; Bernhard Frey; Rudolf Berger; E Hartter; Richard Pacher
Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failure.
Transplantation proceedings 1999;31(1-2):155-7.
1998: Martin Hülsmann; Brigitte Stanek; Bernhard Frey; Brigitte Sturm; D Putz; Thomas Kos; Rudolf Berger; Wolfgang Woloszczuk; D Putz; T Kos; R Berger; W Woloszczuk; Gerald Maurer; Richard Pacher
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure.
Journal of the American College of Cardiology 1998;32(6):1695-700.
1998: Sibylle A Kozek-Langenecker; Oliver Wanzel; Rudolf Berger; Stephan C Kettner; F Coraim
Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
Anesthesia and analgesia 1998;87(5):985-8.
1998: M Wutte; Martin Hülsmann; Rudolf Berger; Suzanne Rödler; Bernhard Frey; Brigitte Stanek; Richard Pacher
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wiener klinische Wochenschrift 1998;110(13-14):473-8.
1997: Richard Pacher; Brigitte Stanek; Martin Hülsmann; Anja Bojic; Rudolf Berger; Bernhard Frey; A Siegel; Thomas Kos; Egon Ogris; Michael Grimm; Günther Laufer
Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1997;16(8):878-81.
1997: Martin Hülsmann; Brigitte Stanek; Bernhard Frey; Rudolf Berger; Suzanne Rödler; A Siegel; E Hartter; M Schuller; Egon Ogris; Richard Pacher
Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1997;16(5):556-62.
1997: Richard Pacher; Martin Hülsmann; Rudolf Berger; J Koller-Strametz; Thomas Kos; Bernhard Frey; A Dukat; Brigitte Stanek
Effects of atenolol as add-on therapy to fosinopril in heart failure.
Wiener klinische Wochenschrift 1997;109(7):232-8.
1997: Richard Pacher; Brigitte Stanek; Martin Hülsmann; Rudolf Berger; A Siegel; H Daneschvar; Suzanne Rödler; Bernhard Frey; Michael Grimm; Günther Laufer
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
European heart journal 1997;18(2):318-29.
1996: Richard Pacher; Brigitte Stanek; Sebastian Globits; Rudolf Berger; Martin Hülsmann; M Wutte; Bernhard Frey; M Schuller; E Hartter; Egon Ogris
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
European heart journal 1996;17(8):1223-32.
1996: M Wutte; Martin Hülsmann; Rudolf Berger; A Siegel; Brigitte Stanek; Richard Pacher
Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1996;15(3):317-8.
1996: Richard Pacher; Brigitte Stanek; Martin Hülsmann; J Koller-Strametz; Rudolf Berger; M Schuller; E Hartter; Egon Ogris; Bernhard Frey; Gottfried Heinz; Gerald Maurer
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
Journal of the American College of Cardiology 1996;27(3):633-41.
1995: Bernhard Frey; M Wutte; Rudolf Berger; C Ioannides; Martin Hülsmann; Brigitte Stanek; Richard Pacher
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Pacing and clinical electrophysiology : PACE 1995;18(1 Pt 2):152-8.
1994: Richard Pacher; Sebastian Globits; M Wutte; Suzanne Rödler; Gottfried Heinz; G Kreiner; S Radosztics; Rudolf Berger; I Presch; H Weber
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Critical care medicine 1994;22(7):1084-90.